FINISHED DOSAGE FORMULATIONS
DEXTROSE MONOHYDRATE
Route : INTRAVENOUS
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 5
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DEXTROSE MONOHYDRATE
Route : INTRAVENOUS
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 5.05
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DEXTROSE MONOHYDRATE
Route : INTRAVENOUS
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 5
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DEXTROSE MONOHYDRATE
Route : NASAL
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 5.5
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DEXTROSE MONOHYDRATE
Route : NASAL
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 0
Potency Unit : NA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DEXTROSE MONOHYDRATE
Route : ORAL
CAS : 77938-63-7
UNII : LX22YL083G
Potency Amount : 46.2
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
Brand Name : LYCADEX® BIOPHARMA
Application : Parenteral
Excipient Details : It is used upstream in the cell culture process as an energy and carbon source during the production of therapeutic proteins
Pharmacopoeia Ref : EP/USP
Technical Specs : Not Available
Ingredient(s) : Dextrose Monohydrate, low endotoxin
Application : Parenteral
Excipient Details : It is a dextrose monohydrate pyrogen-free that is a physiological sugar used to provide excipient and API benefits.
MARKET PLACE